Private Market View

Celmatix

Drug Discovery

Last price · $/share
Implied valuation
Total raised
$19.6M
Last round
Accelerator/Incubator
Jan 2020
Valuation — not yet established

No valuation for Celmatix is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($19.6M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 6 rounds
  • ·Watchlist + deal alerts for Celmatix
Create free account
No card required

Funding history

6 rounds
DateRoundRaisedPost-money
Jan 2020Accelerator/Incubator
Mar 2016Seed Round$4.8M
Aug 2015Seed Round$3.8M
Dec 2014Early Stage VC$5.5M
Feb 2013Seed Round$4.0M
Feb 2012Seed Round$1.5M

How Celmatix's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Celmatix, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

How much has Celmatix raised?
Celmatix has raised $19.6M in total funding across 6 recorded rounds.
When did Celmatix last raise?
Celmatix last raised in Jan 2020 (Accelerator/Incubator).